Clik here to view.
Ankle-Brachial Index, Cardiac Ankle Vascular Index May Indicate Risk of...
Clinical management of patients with chronic myelogenous leukemia (CML) who are receiving tyrosine kinase inhibitors (TKIs) may be improved by assessing ankle-brachial blood pressure index (ABI) and...
View ArticleClik here to view.
Seroconversion After COVID-19 Vaccination High in CML, Low in NHL
The following article features coverage from the 2021 American Society of Hematology Annual Meeting. Click here to read more of Cancer Therapy Advisor’s conference coverage. About 15% of patients with...
View ArticleClik here to view.
Asciminib Continues to Demonstrate Superior Efficacy vs Bosutinib in Chronic...
The following article features coverage from the 2021 American Society of Hematology Annual Meeting. Click here to read more of Cancer Therapy Advisor’s conference coverage. An updated analysis of the...
View ArticleClik here to view.
Many Oncology Drugs Approved for Genomic Indications Not Studied for Overall...
There is a lack of survival data for many oncology drugs approved for genomic indications in recent years, according to research published in the European Journal of Cancer. Researchers looked at drugs...
View ArticleClik here to view.
Duration of TKI Treatment Predicts Early, Late Recurrence in Chronic Myeloid...
The following article features coverage from the 2021 American Society of Hematology Annual Meeting. Click here to read more of Cancer Therapy Advisor’s conference coverage. The duration of tyrosine...
View ArticleClik here to view.
Chronic Myeloid Leukemia: 5 Myths You May Encounter
Misconceptions about chronic myeloid leukemia (CML) may present a barrier to treatment. As a clinician, it’s important to remain alert of potential misunderstandings your patients may have. Here are 5...
View ArticleClik here to view.
Asciminib Shows Early Promise as Frontline Therapy for CML-CP
Early results appear promising for frontline asciminib in patients with chronic phase chronic myeloid leukemia (CML-CP), according to a presentation at the 2022 ASH Annual Meeting. Asciminib produced...
View ArticleClik here to view.
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
Olverembatinib has demonstrated antitumor activity in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), new research suggests....
View ArticleClik here to view.
ChatGPT and the Future of Health Care
In the past year, discussion of digital health and, specifically, the impact of artificial intelligence (AI) has made headlines. Digital health refers to the use of technology, such as mobile devices,...
View ArticleClik here to view.
Preventing and Treating Malnutrition in Cancer Patients
Research suggests that malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.1 Malnutrition in cancer has been associated with fewer...
View ArticleClik here to view.
Certain Cancers May Be More Common in Lesbian, Gay, and Bisexual Patients
The prevalence of certain cancers may be higher in lesbian, gay, and bisexual (LGB) patients than in heterosexual patients, according to data published in Cancer Causes & Control. Researchers found...
View ArticleClik here to view.
Increasing Doses May Improve Efficacy of COVID-19 Vaccines in Cancer Patients
After 3 or 4 doses, mRNA-based COVID-19 vaccines are similarly effective in reducing the risk of severe COVID-19 or hospitalization for patients with cancer and the general population, according to...
View ArticleClik here to view.
Wastage of Oral Cancer Drugs Costs More Than $4000 per Patient, Study Suggests
Wastage of oral cancer drugs due to dose modifications or discontinuations resulted in a mean cost of $4290 per patient in a study published in JAMA Oncology.1 Researchers conducted this study to...
View ArticleClik here to view.
Lack of Sleep Linked to Increased Risk of Cancer
Getting less sleep is associated with an increased risk of cancer, according to a study published in the journal Cancer. Researchers found evidence to suggest that individuals who slept less than 6...
View ArticleClik here to view.
Prior Authorization Requirements for Oral Cancer Drugs Have Increased Over Time
Prior authorization requirements for oral cancer drugs on Medicare part D formularies have increased in recent years, according to research published in JAMA. Researchers used Medicare Part D formulary...
View ArticleClik here to view.
How Transportation Insecurity Impacts Cancer Patients
The following article is part of a series highlighting the effects of social determinants of health on cancer care. The other articles in this series address housing insecurity and food insecurity....
View ArticleClik here to view.
Failed Oncology Trials May Cost Up to $60 Billion Per Year
Researchers have estimated that failed oncology trials cost about $50 billion to $60 billion each year.1 As an example of failed development, the researchers evaluated trials designed to test IGF-1R...
View ArticleClik here to view.
How Housing Insecurity Impacts Cancer Patients
The following article is part of a series highlighting the effects of social determinants of health on cancer care. The other articles in this series address transportation insecurity and food...
View ArticleClik here to view.
Short Bouts of Vigorous Physical Activity May Reduce Cancer Risk
Engaging in vigorous physical activity for 3 to 4 minutes per day is associated with a decrease in the risk of cancer among adults who typically don’t exercise, according to research published in JAMA...
View ArticleClik here to view.
How Food Insecurity Impacts Cancer Patients
The following article is part of a series highlighting the effects of social determinants of health on cancer care. The other articles in this series address housing insecurity and transportation...
View Article